BioSig Technologies Inc () CEO Kenneth Londoner tells Proactive its subsidiary ViralClear Pharmaceuticals Inc has formed its Scientific Advisory Board with two industry veterans experienced as both regulators and corporate executives.
Londoner adds what's more, the group adopted a Stockholders Rights Agreement to help protect shareholders.
Add related topics to MyProactive
Create your account: sign up and get ahead on news and events
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of BioSig Technologies, Inc. named herein, including the promotion by the Company of BioSig Technologies, Inc. in any Content on the Site, the...
FOR OUR FULL DISCLAIMER CLICK HERE